EUCTR2005-001431-30-IT进行中（未招募）不适用
A Randomized, Open Label Study Assessing Safety, Tolerability, and Efficacy of an Induction/Maintenance Treatment Strategy Including Lopinavir/ritonavir (LPV/r) plus Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine (FTC) versus Efavirenz (EFV) plus TDF and FTC in Antiretroviral-Naive HIV-1/HCV Co-infected Subjects
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- ABBOTT
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A Randomized, Open Label Study Assessing Safety, Tolerability, and Efficacy of an Induction/Maintenance Treatment Strategy Including Lopinavir/ritonavir (LPV/r) plus Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine (FTC) versus Efavirenz (EFV) plus TDF and FTC in Antiretroviral-Naïve HIV-1/HCV Co-infected SubjectsHIV-1 infectionEUCTR2005-001431-30-IEAbbott GmbH & Co. KG200
进行中（未招募）
不适用
A Randomized, Open Label Study Assessing Safety, Tolerability, and Efficacy of an Induction/Maintenance Treatment Strategy Including Lopinavir/ritonavir (LPV/r) plus Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine (FTC) versus Efavirenz (EFV) plus TDF and FTC in Antiretroviral-Naïve HIV-1/HCV Co-infected SubjectsEUCTR2005-001431-30-GBAbbott GmbH & Co. KG200
进行中（未招募）
不适用
A study to look at how safe, how well the drug is accepted by the body and how the body deals with the drug when a combination of 5-ALA and SFCare given in different doses in Cancer Patients with Anemia brought on by Chemotherapy.Cancer Patients with Solid Tumors with Chemotherapy Induced AnemiaMedDRA version: 16.1Level: PTClassification code 10002034Term: AnaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2013-002645-11-GBSBI Pharmaceuticals Co., Ltd.
已完成
不适用
A randomised, open label, controlled trial to assess the efficacy and safety of dihydroartemisinin-piperaquine for the treatment of primary and the prevention of secondary infections with Plasmodium falciparumncomplicated Plasmodium falciparum malariaInfections and InfestationsPlasmodium falciparum malariaISRCTN88705995niversity of Heidelberg School of Medicine (Germany)500
已完成
不适用
Terlipressin (drug) in Acute Variceal Bleeding (Liver Disease).CTRI/2018/02/011992Institute of liver and Biliary Sciences110